Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06UYI
|
|||
Former ID |
DCL000037
|
|||
Drug Name |
AM103
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Discontinued in Phase 2 | [1] | |
Company |
Amira Pharma.
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H20N4O3
|
|||
Canonical SMILES |
CC(=O)CC1=CC2=CC(=CN=C2N1CC(=O)N)OCC3=NC4=CC=CC=C4C=C3
|
|||
InChI |
1S/C22H20N4O3/c1-14(27)8-18-9-16-10-19(11-24-22(16)26(18)12-21(23)28)29-13-17-7-6-15-4-2-3-5-20(15)25-17/h2-7,9-11H,8,12-13H2,1H3,(H2,23,28)
|
|||
InChIKey |
NNJQMAFPENKSQD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Arachidonate 5-lipoxygenase activating protein (FLAP) | Target Info | Inhibitor | [2] |
NetPath Pathway | IL4 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
WikiPathways | Nuclear Receptors Meta-Pathway | |||
Arachidonic acid metabolism | ||||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026047) | |||
REF 2 | AM103 Experimental Treatment for Respiratory Diseases. Amira Pharmaceuticals/GSK. 2009. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.